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 20 
ABSTRACT 21 
 22 
Myxomatosis and rabbit hemorrhagic disease (RHD) are the major viral diseases that 23 
affect the wild European rabbit (Oryctolagus cuniculus). These diseases arrived in 24 
Europe within the last decades and have caused wild rabbit populations to decline 25 
dramatically. Both viruses are currently considered to be endemic in the Iberian 26 
Peninsula; periodic outbreaks that strongly impact wild populations regularly occur. 27 
Myxoma virus (MV) and rabbit hemorrhagic disease virus (RHDV) alter the physiology 28 
of infected rabbits, resulting in physical deterioration. Consequently, the persistence and 29 
viability of natural populations are affected. The main goal of our study was to 30 
determine if blood biochemistry is correlated with serostatus in wild European rabbits. 31 
We carried out seven live-trapping sessions in three wild rabbit populations over a two-32 
year period. Blood samples were collected to measure anti-MV and anti-RHDV 33 
antibody concentrations and to measure biochemical parameters related to organ 34 
function, protein metabolism, and nutritional status. Overall, we found no significant 35 
relationships between rabbit serostatus and biochemistry. Our main result was that 36 
rabbits that were seropositive for both MV and RHDV had low gamma 37 
glutamyltransferase concentrations. Given the robustness of our analyses, the lack of 38 
significant relationships may indicate that the biochemical parameters measured are 39 
poor proxies for serostatus. Another explanation is that wild rabbits might be producing 40 
attenuated physiological responses to these viruses because the latter are now enzootic 41 
in the study area. 42 
 43 
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 48 
INTRODUCTION 49 
Diseases can represent major threats for wild animal populations because they can lead 50 
to decline and extinction (Viggers et al., 1993; Woodroffe, 1999; Mörner et al., 2002). 51 
In fact, acquiring a better understanding of diseases and pathogens is a crucial but 52 
challenging task in wildlife conservation efforts (Deem et al., 2001). In ecosystems, 53 
host-pathogen relationships help shape patterns of species distribution and persistence 54 
(Dobson and Hudson, 1986; Thomas et al., 2005; Collinge et al., 2006; Hudson et al., 55 
2006). Even though most previous studies have focused on one-host, one-pathogen 56 
systems, such dynamics are actually rare in nature. Individual hosts are often co-57 
infected by multiple pathogens, which interact in complex ways with each other 58 
(Pedersen, 2006). Therefore, studying the mechanisms underlying these interactions is 59 
of primary importance if we wish to predict how pathogens will affect host physiology 60 
and if we want to effectively control target and non-target parasite species. 61 
Despite its relevance for wildlife conservation and management, the physiology of wild 62 
species is rarely studied because physiological parameters are difficult to quantify. 63 
Furthermore, it is challenging to combine physiological information with other data, 64 
such as antibody concentrations, at the population level. By incorporating indices of 65 
host physiological condition into population surveillance and monitoring efforts, we 66 
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will gain deeper insight into the range of host responses and pathogen effects. Such 67 
tools could reveal the status of major pathogens within wild animal populations and 68 
provide a snapshot of a given animal’s physiological state; consequently, they would 69 
serve as more straightforward means of assessing population condition. In this study, 70 
we used the wild European rabbit (Oryctolagus cuniculus) and its two main viral 71 
diseases, myxomatosis and rabbit hemorrhagic disease (RHD), as a model system.  72 
At present, myxomatosis and RHD are endemic diseases in the Iberian Peninsula; they 73 
cause periodic outbreaks that significantly impact natural populations (Calvete et al., 74 
2002). Outbreak patterns suggest that these viruses are in continuous recirculation and 75 
are largely associated with the breeding season; myxomatosis outbreaks occur 76 
predominantly in summer and autumn, while RHD outbreaks occur in winter and 77 
spring. It also appears that the viruses remain in the same areas from one year to the 78 
next (Calvete et al., 2002). Factors such as breeding season length and timing, host 79 
population size, vector abundance, and environmental conditions have major effects on 80 
the duration and potential impact of the epizootics and, ultimately, on virus persistence 81 
within populations (Fouchet et al., 2008). We currently have a good grasp of the 82 
epidemiology and pathology of myxomatosis and RHD, topics that are discussed 83 
extensively in the literature (e.g., Fenner et al., 1953; Liu, 1984; Xu, 1991; Cooke, 84 
2002; Calvete et al., 2002; Stanford et., al 2007; Abrantes et al., 2012). Myxoma virus 85 
(MV) and rabbit hemorrhagic disease virus (RHDV) dramatically alter the physiology 86 
of infected rabbits. These alterations result in the deterioration of physical health, which 87 
we will hereafter refer to as physiological condition (Kerr and Donnelly, 2013). In 88 
general, an individual’s physiological condition is negatively correlated with the degree 89 
of infection burden but positively correlated with immune function (Chandra and 90 
Newberne, 1997; Gershwin et al., 1985; Møller et al., 1998). Therefore, rabbits in poor 91 
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physiological condition may also be more likely to become infected (Nelson and 92 
Demas, 1996; Tompkins and Begon, 1999; Beldomenico et al., 2008). 93 
There is a need for straightforward, reliable methods for assessing the physiological 94 
condition of wild rabbits; past studies suggest that blood biochemistry could be helpful 95 
in this regard (Franzmann and Shwartz, 1988; Hellgrenet al., 1989; Schroeder, 1987; 96 
Hellgrenet al., 1993; Milner et al., 2003). Moreover, as compared to more conventional 97 
measures, biochemical parameters are highly sensitive, meaning they change to reflect 98 
an individual’s physiological state in a matter of minutes. Consequently, the use of 99 
blood biochemistry may make it possible to identify rabbits experiencing extreme stress 100 
in general (Milner et al., 2003). In particular, Cabezas et al. (2006) revealed that 101 
biochemical parameters (e.g. urea nitrogen, total protein, creatinine and albumin) 102 
concentration changed after boosting antibodies against myxomatosis and RHD through 103 
vaccination. Therefore, we could expect that such changes may occur in a wild rabbit 104 
population when the concentration of their natural antibodies increase as a consequence 105 
of an immune response against both viruses. 106 
In this study we monitored blood chemistry/biochemistry and MV and RHDV 107 
serostatus in wild populations of the European rabbits. Our main objectives were the 108 
following 1) to assess the usefulness of biochemical parameters as predictors of an 109 
individual’s physiological condition; 2) to determine if a relationship existed between 110 
serum biochemistry and serostatus such that rabbits in poorer condition are more likely 111 
to be seropositive for MV and RHDV; and 3) to establish baseline values for 112 
biochemical parameters of rabbits with different serostatus in wild rabbit populations. 113 
 114 
MATERIAL AND METHODS 115 
 116 
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Ethics statement 117 
All animal experimentation was carried out in accordance with Spanish and European 118 
regulations (Law 32/2007, R.D. 1201/2005, and Council Directive2010/63/EU, R.D. 119 
53/2013, ECC/566/2015). 120 
 121 
Study site 122 
The study was conducted in Hornachuelos Natural Park (100-700 m a.s.l.), which is 123 
located in a mountainous area in the southwestern Iberian Peninsula (37°49’ N, 5°15’ 124 
W). The climate is Mediterranean, with hot, dry summers and wet, mild winters. Three 125 
enclosures were built and used as breeding zones for rabbits. The primary objective was 126 
to increase local rabbit abundance to boost the numbers of endangered predators. The 127 
three enclosures (E1:3.8 ha; E2: 4.1 ha; E3:2.9 ha) were surrounded by 2.5-m-high 128 
chain-link fence to prevent rabbit emigration and to exclude terrestrial predators (Rouco 129 
et al., 2008). Within the enclosures, 30 artificial warrens were constructed; they 130 
followed a regular distribution pattern. Water and food pellets were supplied ad libitum, 131 
and grasses were sown to increase the availability of fresh food. 132 
 133 
Sampling 134 
From autumn 2008 to spring 2010, we conducted seven live-trapping sessions in each 135 
enclosure. Rabbits were captured using cage traps placed in the proximity of each 136 
warren, as described by Bertó-Moran et al. (2013). This methodology resulted in the 137 
capture of about 50–60% of the rabbits occupying each warren on any given night 138 
(Rouco et al., 2011). 139 
At the trap site, captured animals were marked with individually numbered ear tags and 140 
their sex and mass were recorded. Females and males weighing more than 750 g and 141 
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850 g, respectively, were considered to be adults (Villafuerte, 1994; Alves and Moreno, 142 
1996). 143 
To characterize biochemical parameters and antibody concentrations, blood samples (1-144 
2.5 ml) were collected between 900 and 1600 by venipuncture of the auricular marginal 145 
vein. The blood samples were kept at room temperature, then transported to the field 146 
laboratory where they were centrifuged on the same day as they were extracted. The 147 
serum obtained was stored at -80ºC until further analysis. 148 
 149 
Biochemical and immunological analyses  150 
We processed the serum samples using a COBAS INTEGRA 400 plus analyzer 151 
(Productos Roche España, Madrid, Spain).We determined the concentrations of alanine 152 
aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin (BILI), lactate 153 
dehydrogenase (LDH), gamma glutamyltransferase (GGT), urea (BUN), creatinine 154 
(CREA), albumin (ALB), and total proteins (TP). These biochemical parameters are 155 
indicators of organ function, protein metabolism, and nutritional status, which means 156 
they should be good proxies for physiological condition (Harder and Kirkpatrick, 1994; 157 
Stirrat, 2003). Since they were expressed in different units, they were transformed prior 158 
to analysis to enable comparisons. 159 
Serum concentrations of anti-MV and anti-RHDV antibodies were determined using 160 
commercially available enzyme-linked immunosorbent assay (ELISA) kits; the 161 
diagnostic techniques recommended by the World Organization for Animal Health were 162 
used (OIE, 2012), and we strictly followed the manufacturer instructions. To measure 163 
anti-MV antibodies, sera were diluted 1:40, and a relative immunity index (RI) was 164 
obtained. It was defined as a coefficient between the optical density of controls (positive 165 
and negative) and that of sampled individuals. RI values ranged from 1 to 10. All 166 
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rabbits with an RI > 2 were considered to be antibody positive (CIV TEST CUNI 167 
MIXOMATOSIS, HIPRA Laboratories, Girona, Spain). To measure anti-RHDV 168 
antibodies, the INGEZIM kit for rabbits (INGENASA Laboratories, Madrid, Spain) was 169 
used. Sera were screened using dilutions of 1:200, 1:400, 1:800, and 1:1,600. Samples 170 
with optical densities > 0.3 were considered to be antibody positive, since such antibody 171 
concentrations should be sufficient to confer protection against the disease (see Bertó-172 
Moran et al., 2013). The test’s specificity and sensitivity were 83.1% and 98.5%, 173 
respectively, and there was a 93% correspondence with the reference technique (OIE, 174 
2012). Biochemical and immunological analyses were performed by the Physiological 175 
Ecology Laboratory of the Doñana Biological Station (Seville, Spain). 176 
 177 
 178 
Data analysis 179 
All statistical analyses were performed using R version 3.0.1 (R Core Development 180 
Team, 2013). Employing generalized linear mixed models (GLMM, glmer function, 181 
lme4 package) with a binomial distribution and a logit link function, we tested the 182 
relationships between the different biochemical parameters and serostatus for 183 
individuals in the three enclosures. To reduce heterogeneity, we limited our analyses to 184 
adults. Three sets of analyses were performed: 1) using rabbits seropositive for MV; 2) 185 
using rabbits seropositive for RHDV; and 3) using rabbits seropositive for both MV and 186 
RHDV. To avoid possible confounding effects, in all the analyses, we considered that 187 
individuals were seronegative only if they had neither anti-MV nor anti-RHDV 188 
antibodies. Correlations among biochemical parameters were tested, and ALT, GGT, 189 
BILI, CREA, BUN, and TP were retained as predictor variables in the subsequent 190 
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analyses. Serostatus was the response variable. We also included sex and rabbit density 191 
as predictor variables in the models. Some individuals were sampled more than once by 192 
chance. To account for the increase in type I error (rejection of the null hypothesis when 193 
it is true) due to pseudoreplication (Hurlbert 1984), we included the following random 194 
variable: capture session nested within individual identity nested within enclosure 195 
number. 196 
Prior to running the analyses, all the numeric predictor variables were scaled (except for 197 
“sex”) using the scale function so that their relative importance could be compared. We 198 
selected the best-fit models via backward stepwise selection (anova function with 199 
maximum likelihood, Crawley 2012; p < 0.05 as the threshold value). Each of the final 200 
models contained only the significant predictors. 201 
 202 
RESULTS 203 
Through the course of the study, we got samples from 823 adult rabbits (306, 269, and 204 
248 rabbits in E1, E2, and E3, respectively). A total of 366 samples were seropositive 205 
only to MV, 124 samples were seropositive only to RHDV, 206 samples were 206 
seropositive to both, MV and RHDV, and 321 samples were seronegative. Some 207 
individuals were sampled more than once, and not always had the same antibody titres, 208 
that is why the number of samples obtained does not math with the total number of 209 
individual animals handled. 210 
None of the biochemical parameters analyzed were significantly associated with MV or 211 
RHDV serostatus. The only significant relationships we found were a positive 212 
association between rabbit density and MV seropositivity (p < 0.001; Table 1) and a 213 
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negative association between GGT levels and seropositivity to both viruses (p < 0.05; 214 
Table 1). 215 
Each enclosure displayed different seroprevalence patterns (Figure 1). In E1, the 216 
percentage of rabbits seropositive for MV, RHDV, or both remained fairly constant 217 
over time. More specifically, MV seroprevalence was high for most of the trapping 218 
sessions. In contrast, RHDV seroprevalence was low; it peaked at 24.4% in session 3. In 219 
E2, the percentage of seronegative rabbits was generally higher than in E1 and E3, with 220 
values reaching a maximum of 63.8 and 69.4% in sessions 1 and 2. MV seroprevalence 221 
increased from session 3 to session 7, whereas the percentage of seronegative rabbits 222 
clearly declined. Remarkably, no rabbits were seropositive for RHDV in session 7. In 223 
E3, there was a higher percentage of individuals that were seropositive for both viruses, 224 
as compared to E1 and E2. It was also the enclosure with the lowest percentage of 225 
seronegative rabbits; this value climbed as high as 55.6% in session 4. Notably, there 226 
were no seronegative rabbits in sessions 1 and 7. Rabbits seropositive for MV and for 227 
RHDV were observed in every session, but their percentages were rather low. RHDV 228 
seroprevalence peaked in all three enclosures in session 3. 229 
In general, the ranges of values observed for the biochemical parameters remained fairly 230 
consistent, although some noticeable changes in certain parameters occurred during 231 
certain capture sessions (Figure 2). In E1, most of the biochemical parameters had 232 
relatively constant values, but GGT and BILI fluctuated slightly. The pattern in E2 was 233 
more heterogeneous. Almost all the parameters varied somewhat, except for BUN, TP, 234 
ALB, and BILI. In the case of the transaminases—ALT, AST, and GGT—maximum 235 
values occurred in sessions 2, 5, and 7. CREA levels were fairly constant over time but 236 
hit a low in session 3, which coincided with the minimum values for the transaminases. 237 
Blood biochemistry patterns were most distinct in E3. As in E2, BUN, TP, ALB, and 238 
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BILI varied little while the transaminases and CREA fluctuated dramatically. ALT and 239 
AST followed parallel patterns, both peaking in sessions 4, 6, and 7 and dropping to 240 
their minimum values in session 2. GGT presented an irregular pattern—levels were 241 
highest in session 4 and dipped down in sessions 3, 5, and 7. While CREA tended to 242 
remain constant, it dropped sharply after peaking in session 5. 243 
Table 2 provides the means for the different biochemical parameters for the different 244 
enclosures and seropositivity classes; it also gives more detailed information related to 245 
the aforementioned patterns. 246 
 247 
DISCUSSION 248 
To our knowledge, this is the first study conducted in the field to address the 249 
relationship between MV and RHDV seropositivity and the physiological status of wild 250 
European rabbits using large numbers of animals and in the context of a long-term 251 
monitoring program. 252 
In light of the results, we found limited evidence for an association between blood 253 
biochemistry and serostatus in wild European rabbit populations. The only significant 254 
relationship we observed was that rabbits seropositive for both MV and RHDV had 255 
lower GGT concentrations (Table 1). However, the lack of significant findings might be 256 
due to spurious results generated by data heterogeneity and the presence of confounding 257 
variables. 258 
One major methodological handicap is the scarcity of data on wild rabbit populations. 259 
Most studies dealing with myxomatosis and RHD have focused on disease pathology 260 
and epidemiology in domestic rabbits. Consequently, most of the information currently 261 
available has been obtained using rabbits reared under laboratory conditions (Calvete et 262 
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al., 2002; Calvete et al., 2005; Cabezas et al., 2006; Kerr, 2012). However, 263 
physiological data for domestic rabbits is not directly comparable to that for wild rabbits 264 
since major differences exist in genetics, environmental contexts, breeding conditions, 265 
individual responsiveness, and even laboratory processes and techniques. In addition, 266 
laboratory rabbits usually develop physiological problems and specific pathologies as a 267 
result of living in captivity. These limitations aside, our results suggest that 268 
myxomatosis and RHD have declined in severity because they have become endemic in 269 
the Iberian Peninsula (Ross et al., 1986; Ross et al., 1989; Marchandeau et al., 1999; 270 
Calvete et al., 2002; Marchandeau et al., 2014). Endemic diseases have strong initial 271 
effects and cause high mortality rates in afflicted populations. However, the individuals 272 
that survive experience constant reinfections over time, ultimately leading to high 273 
immunity levels within populations. As a result, individuals become partly protected 274 
and most show mild clinical symptoms throughout the year. The pathogen can then be 275 
said to be in permanent circulation and to have become enzootic (Calvete et al., 2002; 276 
Cooke, 2002; Fouchet et al., 2008). This state of affairs is consistent with our results 277 
(Figure 1). Although the three enclosures exhibited some distinct differences, in 278 
general, there were always some individuals seropositive for MV, RHDV, or both 279 
throughout the study period. This finding suggests that the two viruses are now endemic 280 
in the study populations. It is also worth noting the fluctuating percentage of 281 
seronegative rabbits seen in E3: there were no seronegatives at the beginning or at the 282 
end of the study period. In E2, no RHDV-seropositive rabbits were found in the last 283 
capture session. Individuals with severe RHDV infections might have died, leaving no 284 
seropositives in the population; consequently, new outbreaks may result in high 285 
mortality rates. This pattern might be linked to the severity of RHD and its relatively 286 
more recent arrival, as compared to myxomatosis.  287 
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When we looked at the results for rabbit biochemistry and serostatus in tandem for the 288 
different enclosures, we observed that both were highly homogenous in E1. In E2, 289 
transaminases and CREA peaked in session 2, which was when the percentage of 290 
seronegative rabbits was the highest. The number of seronegative rabbits declined over 291 
subsequent sessions, while rabbits seropositive for MV, for RHDV, and for both 292 
became more abundant. One possible explanation is that E2 rabbits were exposed to the 293 
viruses around the time of session 2 (there were a number of outbreaks that season, as 294 
described in the literature [i.e., Calvete et al., 2002]), which is suggested by the session 295 
2 peak in transaminases. In sessions 3 and 4, the number of seropositive rabbits 296 
increased and both the transaminases and CREA dropped to their minimum values.  297 
This result lends support to the idea that rabbits that have been exposed to the viruses, 298 
and that consequently develop immunity, are likely to return to basal biochemical 299 
parameter values. 300 
In E3, transaminases peaked in session 4, which is also when the number of 301 
seronegative rabbits was highest. In the subsequent capture sessions (sessions 5 and 6), 302 
the percentage of seronegative individuals declined sharply while the number of 303 
individuals seropositive for MV, RHDV, or both climbed. This pattern probably 304 
resulted from a high incidence of the diseases in session 4 and earlier. The population’s 305 
exposure to the viruses can be seen in the increase in transaminases in session 4, which 306 
is when they reached maximum levels. In sessions 5, 6, and 7, after rabbits had become 307 
seropositive, the transaminases were close to their minimum levels, suggesting that 308 
immune (seropositive) rabbits tended to return to basal parameter levels. 309 
As in E2, in E3 there were large numbers of seronegative rabbits in sessions 2 and 3, 310 
just before transaminases peaked in session 4, which likely signaled the beginning of an 311 
endemic disease cycle.  312 
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Of the biochemical parameters studied, the transaminases (ALT, AST, and GGT) were 313 
clearly the most variable for all three enclosures. This pattern may reflect the impaired 314 
hepatic function seen in rabbits infected with MV and/or RHDV. 315 
In addition to the shortcomings mentioned above, the lack of significant findings puts 316 
into question the utility of biochemical parameters in assessing the physiological 317 
condition of European rabbits. As is clear from the literature, serum biochemistry might 318 
be influenced by a variety of factors, including rabbit handling and sampling 319 
procedures, fieldwork conditions, and animal nutritional and health status at the time of 320 
sampling (Calvete et al., 2005; Cabezas et al., 2006). Furthermore, there is individual-321 
level variation in immune and physiological responses as a result of trade-offs between 322 
environmental conditions and life-history traits (e.g., developmental, physiological, 323 
genetic, and immunological traits) (Ardia et al., 2011). Therefore, alternative indicators 324 
such as concentrations of specific immunoglobulins (e.g., IgM or IgG) or cellular 325 
oxidative stress markers could provide more complete and precise information. 326 
As discussed above, confounding variables that were not accounted for in our analyses 327 
could be skewing our results. Such variables could include the following: (1) rabbit age; 328 
(2) outbreak timing; (3) the ELISA seropositivity thresholds; (4) the response speed of 329 
biochemical parameters; and (5) the lack of reference values for wild rabbits.  330 
One major factor could be rabbit age. In this study, we estimated age based on mass. 331 
Although this approach can separate adult rabbits from non-adult rabbits, it cannot 332 
reveal a rabbit’s precise age. Knowing a rabbit’s age could be important because as 333 
rabbits get older, their probability of being infected by a wide variety of potentially 334 
serious pathogens like MV or RHDV increases, as do antibody levels (Marchandeau et 335 
al., 1995; Parkes et al., 2002; Parkes et al., 2008). Furthermore, a rabbit’s innate 336 
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responsiveness changes over its lifetime, which means that individuals of different ages 337 
will have different biochemical profiles and immunological experience.                                                                                             338 
Outbreak timing is also important but difficult to characterize. Myxomatosis and RHD 339 
outbreaks show some seasonal and geographic variation (Mutze et al., 2008; Mutze et 340 
al., 2010; Abrantes et al., 2012). More specifically, the occurrence of epizootics might 341 
vary across years and even among populations (i.e., enclosures) as a result of delayed 342 
breeding and variable climatic conditions, which can affect the abundance and activity 343 
of the pathogens’ vectors. Determining the moment of infection is nearly impossible, so 344 
outbreak timing is only approximate.  345 
As mentioned above, wild rabbits are naturally exposed to a wide variety of pathogens, 346 
whereas laboratory rabbits are artificially infected with a smaller selection of them. The 347 
ELISA techniques that we used to determine MV and RHDV seropositivity were 348 
developed using European rabbits kept under laboratory conditions. It may be that 349 
applying such seropositivity thresholds to wild rabbits could yield false positives and 350 
cross-reactions since laboratory rabbits are exposed to fewer pathogen species and thus 351 
have lower threshold antibody concentrations than wild rabbits (Kerr, 1997). 352 
Finally, the response speed of biochemical parameters must be accounted for. Serum 353 
biochemistry changes are relatively transient, as demonstrated by several studies in 354 
which rabbits were artificially infected with pathogens (Ferreira et al., 2004). Rabbits 355 
show an initial physiological response to infection, but if they do not die, any changed 356 
biochemical parameters revert to their basal values. Nevertheless, such shifts are likely 357 
to go undetected in the wild.  358 
In conclusion, it will be important to carry out further research that explores 359 
straightforward, reliable indices that can be used to assess the physiological condition of 360 
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individuals in target wildlife populations. Selecting the right methods and biochemical 361 
parameters is essential if we wish to more rapidly detect and control diseases in wild 362 
species, which would help improve management and conservation programs.  363 
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Table 1. Results for the generalized mixed models for each dataset (i.e., MV: rabbits seropositive for myxoma virus; RHDV: rabbits 
seropositive for rabbit hemorrhagic disease virus; MV & RHDV: rabbits seropositive for both viruses). Coefficient estimates (β), estimated 
standard errors (SE), and p-values (p) are listed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 MV RHDV MV & RHDV 
 Β SE p β SE p β SE p 
          
ALT 0.2042 0.1241 0.09433 0.1940 0.1646 0.2486 0.2391 0.1362 0.08241 
GGT 0.01504 0.11533 0.8961 -0.06207 0.17053 0.7131 -0.3031 0.1599 0.0491* 
BILI -0.07875 0.10509 0.453 -0.2079 0.1636 0.192 -0.1320 0.1427 0.3639 
CREA -0.04941 0.10756 0.6478 -0.03273 0.17178 0.8467 -0.1195 0.1651 0.4781 
BUN 0.04409 0.10948 0.686 -0.01682 0.14124 0.9006 0.07518 0.11388 0.5182 
ALB -0.04380 0.11618 0.7065 0.02039 0.16918 0.8993 0.08296 0.14723 0.5847 
density 0.3728 0.1112 0.000804* -0.03413 0.17652 0.8461 0.01127 0.14411 0.9383 
Sex 0.2173 0.2155 0.3112 0.10556 0.29962 0.7248 0.3539 0.2554 0.1703 
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Table 2. Blood biochemistry of wild European rabbits in the three study enclosures; rabbits are grouped by serostatus (seronegative, seropositive 
for myxoma virus [Myxo+], seropositive for rabbit hemorrhagic disease virus [Rhd+], and seropositive for both viruses [Myxo+/Rhd+]). Values 
correspond to the mean ± SE. 
 
 E1 E2 E3 
Parameter(units) seronegative Myxo+ Rhd+ Myxo+/Rhd+ seronegative Myxo+ Rhd+ Myxo+/Rhd+ seronegative Myxo+ Rhd+ Myxo+/Rhd+ 
ALT (U/L) 9±0.7 8.5±0.9 9.6±0.5 10.1±0.9 12.6±0.8 14.7±1.8 13.8±1.0 15.1±2.0 19.6±2.1 20±2.0 21±1.4 20.3±1.2 
AST (U/L) 32.2±3.2 31.4±3.2 31.9±1.9 38.1±5.0 44.8±3.0 46.4±6.3 48.3±4.1 39.8±3.9 66±9.1 56.8±6.1 60.8±4.0 65.3±5.1 
GGT(U/L) 6.9±0.6 7±0.7 7.4±0.4 7.1±0.6 9.2±0.6 8±1.1 8.4±0.5 8±0.8 9.2±0.9 9.3±0.9 10.3±1.3 7.4±0.4 
BILI (μmol/L) 1.4±0.1 1.2±0.1 1.4±0.1 1.3±0.1 1.7±0.1 1.6±0.1 1.7±0.1 1.5±0.2 1.7±0.2 1.7±0.1 1.8±0.1 1.7±0.1 
CREA (mg/dl) 0.8±0.04 0.8±0.07 0.8±0.02 0.8±0.05 0.9±0.04 0.8±0.07 0.8±0.05 0.9±0.1 1±0.2 0.9±0.1 1±0.1 0.9±0.05 
BUN(mg/dl) 73.7±4.8 76.2±7.9 74±2.2 71.9±3.4 70.4±2.6 66±4.9 77.7±2.3 73.2±5.7 76.5±5.1 77.7±3.3 72.4±3.3 79.8±3.4 
LDH(U/L) 643.1±43.5 647.7±34 697.8±44.0 697.4±64.6 670.5±37.9 582.9±52.4 703±36.9 740±91.8 890±98.0 743.2±95.7 918.9±73.2 862.4±63.5 
ALB(g/dl) 4.8±0.1 5±0.2 4.7±0.1 4.7±0.1 4.9±0.1 4.5±0.2 4.9±0.1 5±0.1 4.5±0.2 4.7±0.1 4.7±0.1 4.6±0.1 
TP (g/dl) 5.7±0.2 6.1±0.4 5.7±0.1 6±0.4 5.8±0.1 5.4±0.2 5.8±0.1 5.7±0.3 5.4±0.2 5.7±0.1 5.8±0.1 5.8±0.1 
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FIGURES CAPTIONS 
Figure 1. Variation in MV and RHDVseroprevalence in rabbit populations (E1, E2, and E3) over the 
two-year study period 
 
Figure 2. Transformed values (mean ± SE) of biochemical parameters for each capture 526 
session in the three study enclosures (E1, E2, and E3).Alanine aminotransferase (ALT), 527 
aspartate aminotransferase (AST), bilirubin (BILI), lactate dehydrogenase (LDH), 528 
gamma glutamyltransferase (GGT),  urea (BUN), creatinine (CREA), albumin (ALB), 529 
and total proteins (TP) 530 
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FIGURE 1 532 
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